Affiliation:
1. Endocrine and Metabolic Diseases Research Center, School of Medicine, University of Zulia, Maracaibo,
Venezuela
2. Psychiatric Hospital of Maracaibo, Maracaibo, Venezuela
Abstract
Abstract:
Obesity is a multifactorial metabolic condition characterized by an abnormal or excessive
accumulation of fat in the adipose tissue, capable of decreasing life expectancy. Chronically,
the exacerbated inflammatory response interferes with the proper functioning of organs
and tissues, becoming the cornerstone of various major metabolic imbalances in different systems,
such as the central nervous system. Considering this, obesity’s meta-inflammation indirectly
affects brain regions related to psychiatric illnesses and cognitive function. Also, it has
been established that several neurobiological mechanisms related to appetite regulation and
impulse control disorders could explain the onset of obesity. Thus, due to the high prevalence
of mental illnesses linked to obese patients and the fact that a bidirectional relation between
these two entities has been observed, many efforts have been made to establish an effective and
secure pharmacological approach to obesity. In this context, several psychotropics and appetite-
suppressant drugs, along with lifestyle changes, have been highlighted as promising therapeutic
tools against obesity.
Publisher
Bentham Science Publishers Ltd.
Subject
Psychiatry and Mental health